PR Newswire Asia's news > Medical/Pharmaceuticals

 |   Title only   |   Print    Next page > 
     
Seegene unveils the world's first unattended PCR automation, igniting a global diagnostic paradigm shift at ADLM 2025
Fully Unmanned— CURECA™, the 100% Automated Diagnostic System Defining the Future Gold Standard, Debuts in Chicago , July 28–31 Unifying global diagnostic data - STAgora™, the big data platform set ...
2025-07-23T    Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
HBM9378/WIN378, a Long-Acting, Fully Human Anti-TSLP Antibody, Enters Global Phase 2 POLARIS Trial for Asthma
Phase 2 POLARIS trial will evaluate the dosing, safety, and efficacy of HBM9378/WIN378 in patients with asthma, with an initial data readout expected in mid-2026 HBM9378/WIN378 has the potential ...
2025-07-23T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Elevating Care: GuidelineX Showcases AI-Powered Clinical Decision Support System at HIMSS APAC 2025
KUALA LUMPUR, Malaysia , July 23, 2025 /PRNewswire/ -- At the HIMSS APAC 2025 conference, GuidelineX made a powerful impact with its next-generation, AI-native Clinical Decision Support System ...
2025-07-23T    Computer/Electronics   Health Care/Hospital   Medical/Pharmaceuticals   Trade show news 
Singapore-Based Innovative Biomedical Start-Up Achieves 'Strategic Triumph' to Conquer Chinese Med-Tech Market
NMPA grants Syntellix product approval for the world's most important future market with more than 1.4 billion people Syntellix' product approval for China is the largest and most important success ...
2025-07-23T    Biotechnology   Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
Landmark Trial Demonstrates Efficacy of Microcurrent Therapy in Heart Failure: C-MIC II Results Published in the European Journal of Heart Failure
ZUG, Switzerland , July 23, 2025 /PRNewswire/ -- Berlin Heals and the C-MIC II Investigators today announced the publication of the C-MIC II trial results in the  European Journal ...
2025-07-23T    Health Care/Hospital   Medical/Pharmaceuticals 
Zylox-Tonbridge Issues Positive Profit Alert, Expects Over RMB 115 Million in 1H 2025 Net Profit
HANGZHOU, China , July 23, 2025 /PRNewswire/ --  Zylox-Tonbridge Medical Technology Co., Ltd. (HKEX: 2190, "Zylox-Tonbridge" or the "Company"), a leading medical device company ...
2025-07-23T    Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
Samsung Biologics reports second quarter 2025 financial results
Recorded Q2'25 consolidated revenue of KRW 1,289.9 billion Recorded Q2'25 consolidated operating profit of KRW 475.6 billion Solid momentum sustained through capacity ramp-up and stable project ...
2025-07-23T    Biotechnology   Environmental Products & Services   Health Care/Hospital   Medical/Pharmaceuticals 
BostonGene Receives Frost & Sullivan's 2025 North American Enabling Technology Leadership Award for Redefining Precision Oncology with AI and Multiomics Innovation
BostonGene's comprehensive AI-powered platform integrates multiomics data to accelerate discovery, reduce development risk and advance precision oncology across all stages the R&D co ...
2025-07-22T    Biotechnology   Computer/Electronics   Health Care/Hospital   Medical/Pharmaceuticals 
A novel oral treatment for Alzheimer's: Actinogen's pivotal trial currently recruiting participants in the US
All 20 US trial sites are now open in the XanaMIA phase 2b /3 trial that is studying oral Xanamem ®  vs. placebo for 36 weeks, followed by an open label extension of active Xanamem for up to ...
2025-07-22T    Health Care/Hospital   Medical/Pharmaceuticals 
Telix Reports $204M Revenue, Up 63% YOY
MELBOURNE , Australia and INDIANAPOLIS , July 22, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today provides an update on its commercial and ...
2025-07-22T    Health Care/Hospital   Medical/Pharmaceuticals 
  Next page >

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2025 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.